All Antimicrobial resistance (AMR) articles
-
Industry newsCVMP June 2026 meeting update: Vaccines, guideline reviews and an AMR strategy refresh
The Committee for Veterinary Medicinal Products (CVMP) met on 16-18 June 2026. Alongside its usual product decisions, the Committee advanced two guideline reviews for sponsors working on vaccines and other immunological products.
-
JournalBeyond borders: Strengthening regional regulatory frameworks to end substandard and falsified medicines in Africa
This analysis examines the regulatory, economic and supply chain dynamics underpinning the issue of substandard and falsified medicines in Africa, and explores how regional harmonisation initiatives, emerging technologies and strengthened enforcement mechanisms can protect public health across the continent
-
Industry newsEMA ETF offers scientific advice for antimicrobial resistance
This is an industry news update about the EMA’s ETF that offers scientific advice for antimicrobial resistance.
-
ContentsNovember 2025 – Contents: Veterinary medicines sessions
The November issue of Regulatory Rapporteur reports on the veterinary medicines sessions from the TOPRA Symposium 2025.
-
ContentsRegulatory Rapporteur November 2025 – Contents
The November issue of Regulatory Rapporteur reports on sessions from the TOPRA Symposium 2025.
-
JournalPromoting the use of bacteriophages in animals to reduce antimicrobial resistance
This article explores bacteriophage-based products for animals and how to reduce antimicrobial resistance (AMR).
-
ContentsJune 2025 – Contents
The June issue of Regulatory Rapporteur focuses on veterinary medicines.
-
EditorialVeterinary medicines: Translating regulation into practice
This issue looks at the impact of the Veterinary Regulation 2019/6, the effect of the new EMA fees on marketing authorisation holders, and the regulatory challenges associated with the practical use of bacteriophages in veterinary medicine.
-
Industry newsEMA to address antimicrobial resistance risks from veterinary medicinal products
The European Medicines Agency (EMA) has published a new concept paper outlining plans to assess the risks of humans developing AMR from VMPs via the environment.
-
-
-
-
Industry newsAI used to predict candidate antibiotics in radical study
AI machine learning algorithms have been used in a study to identify candidate compounds for investigation as potential new antibiotics.
-
Industry newsUnchecked AMR could make COVID-19 pandemic ‘minor’
Professor Dame Sally Davies has warned that unchecked antimicrobial resistance could make the COVID-19 pandemic ’look minor’.